Hi all, The March issue of the HCV Advocate newsletter is available.

It's disappointing that the FDA will not be giving out any more Priority Reviews to HCV treatments. What about the Geno 3's?

Also it's good to see that patients with a SVR can expect a 'normal' life span. Cheers.

http://www.hcvadvocate.org/news/newsLetter/2015/advocate0315.html#1